Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Intermittent Celecoxib in Osteoarthritis
NCT00139776Phase 4Completed
- Sponsor
- Viatris
- Start
- Jul 2005
- Primary completion
- Feb 2008
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
Phase 4, randomised, double-blind trial of celecoxib in osteoarthritis (OA) (2 arms), sponsored by Viatris. Primary endpoint: Number of Flare Events Per Time of Exposure to Study Medication at 22 weeks. Started Jul 2005; status: completed.
02
Drugs
celecoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00139776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139776.